Clinical Trial Update: Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose and multiple ascending dose study in healthy volunteers and ulcerative colitis patients; the trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Healthy Volunteers, Ulcerative Colitis | Phase 1 | Status: TERMINATED